top of page
News, Events and Updates
Search
Mar 3, 2015
Anavex to Present at 27th Annual ROTH Conference on March 11th
Mar 3, 2015
Alzheimer's Australia Dementia Research Foundation
Feb 25, 2015
ANAVEX 2-73 Could Prevent Alzheimer's Disease in Addition to Modifying and Treating Symptoms
Feb 18, 2015
Amarantus Announces First Alzheimer's Biomarker Services Collaboration for LymPro® Test with Anavex
Feb 18, 2015
Anavex Report Fiscal First Quarter 2015 Financial Results
Feb 9, 2015
Anavex Confirms Positive Preclinical Epilepsy Data for ANAVEX 2-73
Feb 4, 2015
Anavex to Present at 17th Annual BIO CEO & Investor Conference on February 10th
Jan 20, 2015
Mitochondrial Protection by the Mixed Muscarinic/Sigma-1 Ligand ANAVEX2-73
Jan 12, 2015
Anavex Doses First Alzheimer's Patient in Phase 2a Trial of ANAVEX 2-73 and ANAVEX PLUS
Jan 8, 2015
Anavex Announces Panel Discussion and Presentation at OneMedForum Conference
Jan 6, 2015
Anavex Encouraged by Scientific Data Confirming Sigma-1 Receptor's Beneficial Direct Interaction
34
35
36
37
38
Stay Connected
Follow us on social media
Newsroom
Webcast Library
Contact Us
Back to Newsroom
bottom of page
